Bank of New York Mellon
VERA icon

Bank of New York Mellon’s Vera Therapeutics VERA Stock Holding History

Bank of New York Mellon’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.48M Buy
197,694
+18,340
+10% +$683K ﹤0.01% 2121
2026
Q1 		$7.22M Buy
179,354
+9,620
+6% +$414K ﹤0.01% 2109
2025
Q4 		$8.6M Buy
169,734
+8,193
+5% +$291K ﹤0.01% 2014
2025
Q3 		$4.69M Buy
161,541
+2,448
+2% +$56.6K ﹤0.01% 2358
2025
Q2 		$3.75M Buy
159,093
+15,428
+11% +$347K ﹤0.01% 2433
2025
Q1 		$3.45M Buy
143,665
+1,717
+1% +$55.2K ﹤0.01% 2416
2024
Q4 		$6M Buy
141,948
+7,895
+6% +$350K ﹤0.01% 2196
2024
Q3 		$5.93M Sell
134,053
-31,269
-19% -$1.19M ﹤0.01% 2213
2024
Q2 		$5.98M Buy
165,322
+9,854
+6% +$391K ﹤0.01% 2245
2024
Q1 		$6.7M Buy
155,468
+24,150
+18% +$861K ﹤0.01% 2176
2023
Q4 		$2.02M Buy
131,318
+3,086
+2% +$39.2K ﹤0.01% 2829
2023
Q3 		$1.76M Sell
128,232
-1,975
-2% -$33.9K ﹤0.01% 2881
2023
Q2 		$2.09M Buy
130,207
+32,227
+33% +$291K ﹤0.01% 2807
2023
Q1 		$760K Buy
97,980
+26,210
+37% +$202K ﹤0.01% 3262
2022
Q4 		$1.39M Buy
71,770
+2,272
+3% +$41.1K ﹤0.01% 3041
2022
Q3 		$1.48M Sell
69,498
-5,586
-7% -$105K ﹤0.01% 3013
2022
Q2 		$1.02M Buy
75,084
+26,248
+54% +$458K ﹤0.01% 3200
2022
Q1 		$1.15M Buy
48,836
+28,247
+137% +$608K ﹤0.01% 3226
2021
Q4 		$550K Buy
20,589
+7,365
+56% +$163K ﹤0.01% 3745
2021
Q3 		$230K Buy
+13,224
New +$236K ﹤0.01% 4148

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return

Bank of New York Mellon's VERA Position: Q2 2026 in Review

Bank of New York Mellon increased its Vera Therapeutics (VERA) stake by 10% in Q2 2026, buying an estimated $683K and bringing the position to 197,694 shares worth $8.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

Bank of New York Mellon first reported a position in VERA in Q3 2021 and has held it in 20 quarters since. The position peaked at $8.6M in Q4 2025. 71 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Bank of New York Mellon held 197,694 shares of Vera Therapeutics worth $8.48M as of Q2 2026.
  • Bank of New York Mellon bought 18,340 Vera Therapeutics shares in Q2 2026, an estimated $683K.
  • Vera Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2121 holding.
  • Bank of New York Mellon first reported a position in Vera Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Bank of New York Mellon's Vera Therapeutics position peaked at $8.6M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.